CXCL8 and atopic conjunctivitis: DS70 dose-dependently reduced clinical aspects of allergic conjunctivitis, conjunctival mast cell and eosinophil infiltration, α4 integrin expression, and levels of mRNAs for IL-1β, IL-8 (CXCL8), CCL5, and CCL11, thus representing an alternative to antihistamines and mast cell-stabilizing agents.